Literature DB >> 23727557

An electrochemiluminescence assay for gp340 (DMBT1).

Cheryl Barber1, Drew Weissman, Kurt Barnhart, Minal Dalvi, William R Abrams, Daniel Malamud.   

Abstract

Gp340 is a member of the scavenger receptor cysteine-rich family of innate immune molecules and also functions as a tumor suppressor. This study describes a picogram-level assay using electrochemiluminescence technology on the MesoScale Discovery platform. Antibodies were evaluated and the best pair was used to assay whole-mouth stimulated saliva and cervical/vaginal lavage. The assay was tested using specimens obtained from healthy volunteers to determine if gp340 concentration in saliva correlates with levels in vaginal lavage fluid. Interestingly, no correlation was determined between gp340 content in these two fluids.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical vaginal lavage; MesoScale Discovery; Salivary agglutinin; Scavenger receptor cysteine-rich; Whole-mouth stimulated saliva

Mesh:

Substances:

Year:  2013        PMID: 23727557      PMCID: PMC3719401          DOI: 10.1016/j.ab.2013.05.015

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  26 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

2.  Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; N Lale Satiroglu-Tufan; Canten Tataroglu; Zehra Kesen; Z Ozlem Doğan; Sunde Yılmaz; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2011-09-29       Impact factor: 2.316

3.  Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120.

Authors:  Zhiwei Wu; Donald Van Ryk; Cheryl Davis; William R Abrams; Irwin Chaiken; John Magnani; Daniel Malamud
Journal:  AIDS Res Hum Retroviruses       Date:  2003-03       Impact factor: 2.205

4.  DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.

Authors:  J Mollenhauer; S Herbertz; U Holmskov; M Tolnay; I Krebs; A Merlo; H D Schrøder; D Maier; F Breitling; S Wiemann; H J Gröne; A Poustka
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

5.  Bacterial aggregating activity in human saliva: simultaneous determination of free and bound cells.

Authors:  E E Golub; M Thaler; C Davis; D Malamud
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

6.  Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major high-molecular-mass glycoproteins in human tears.

Authors:  Benjamin L Schulz; David Oxley; Nicolle H Packer; Niclas G Karlsson
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

7.  gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction.

Authors:  Zhiwei Wu; Ellis Golub; William R Abrams; Daniel Malamud
Journal:  AIDS Res Hum Retroviruses       Date:  2004-06       Impact factor: 2.205

8.  DMBT1 expression distinguishes anorectal from cutaneous melanoma.

Authors:  Burkhard Maria Helmke; Marcus Renner; Annemarie Poustka; Peter Schirmacher; Jan Mollenhauer; Michael André Kern
Journal:  Histopathology       Date:  2009-01       Impact factor: 5.087

9.  gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission.

Authors:  Earl Stoddard; Georgetta Cannon; Houping Ni; Katalin Karikó; John Capodici; Daniel Malamud; Drew Weissman
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

10.  Salivary agglutinin/DMBT1SAG expression is up-regulated in the presence of salivary gland tumors.

Authors:  F J Bikker; J E van der Wal; A J M Ligtenberg; J Mollenhauer; J M A de Blieck-Hogervorst; I van der Waal; A Poustka; A V Nieuw Amerongen
Journal:  J Dent Res       Date:  2004-07       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.